Sanofi to Buy Genzyme in $20.1 Billion Deal

by | Feb 16, 2011 | Towing

French drug company Sanofi-Aventis (SNY) has finally made a deal to buy biotech company Genzyme (GENZ) for $20.1 billion, about $74 a share. Genzyme shareholders will get a contingent value right that represents potential future payments if Lemtrada, t…

Genzyme Rejects Sanofi-Aventis Takeover Bid

by | Oct 22, 2010 | Towing

Genzyme, which makes drugs to treat leukemia and multiple sclerosis, has rejected a hostile takeover bid from French drugmaker Sanofi-Aventis. The offer “dramatically undervalues” Genzyme, the company said Friday, putting its v…